Literature DB >> 2554315

Detection and mapping of spliced RNA from a human hepatoma cell line transfected with the hepatitis B virus genome.

T Suzuki1, N Masui, K Kajino, I Saito, T Miyamura.   

Abstract

HepG2 cells, known to support the replication and virion formation of hepatitis B virus (HBV), were transfected with a cosmid constructed to contain 12 tandem head-to-tail repeats of the HBV genome for effective HBV genome expression. We detected previously identified RNAs of 3.3, 2.3, and 2.0 kilobases (kb) that code for core antigen, large surface antigen, and middle/major surface antigen, respectively. We also detected four additional RNAs of 2.1, 1.7, 1.1, and 0.7 kb [the lengths exclude the poly(A) tail]. S1 mapping and nucleotide sequencing data showed that the 2.1-kb RNA is a spliced RNA whose 5' and 3' ends are identical to those of the 3.3-kb RNA. The results suggest that the 2.1-kb RNA codes for an altered core antigen lacking the last amino acid, cysteine, and that expression of the 3.3-kb pregenomic RNA is regulated, at least in part, by splicing. The map positions of the 1.7- and 1.1-kb RNAs suggest that they code for the carboxyl-terminal portions of the putative polymerase, whereas the 0.7-kb RNA codes for the X protein.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554315      PMCID: PMC298294          DOI: 10.1073/pnas.86.21.8422

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

2.  The RNA lariat: a new ring to the splicing of mRNA precursors.

Authors:  W Keller
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

3.  Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA.

Authors:  K Yaginuma; Y Shirakata; M Kobayashi; K Koike
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

4.  Novel RNA family structure of hepatitis B virus expressed in human cells, using a helper-free adenovirus vector.

Authors:  I Saito; Y Oya; H Shimojo
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

5.  Mapping the major transcripts of ground squirrel hepatitis virus: the presumptive template for reverse transcriptase is terminally redundant.

Authors:  G H Enders; D Ganem; H Varmus
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

6.  Replication strategy of human hepatitis B virus.

Authors:  H Will; W Reiser; T Weimer; E Pfaff; M Büscher; R Sprengel; R Cattaneo; H Schaller
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

7.  Identification of a promoter element located upstream from the hepatitis B virus X gene.

Authors:  M Treinin; O Laub
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

8.  Hepatitis B virus transcript produced by RNA splicing.

Authors:  T S Su; C J Lai; J L Huang; L H Lin; Y K Yauk; C M Chang; S J Lo; S H Han
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

9.  Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli.

Authors:  F Galibert; E Mandart; F Fitoussi; P Tiollais; P Charnay
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

10.  Transcriptional control elements of hepatitis B surface antigen gene.

Authors:  A Siddiqui; S Jameel; J Mapoles
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

View more
  18 in total

1.  Evidence that less-than-full-length pol gene products are functional in hepadnavirus DNA synthesis.

Authors:  T T Wu; L D Condreay; L Coates; C Aldrich; W Mason
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

2.  Infection initiated by the RNA pregenome of a DNA virus.

Authors:  M J Huang; J Summers
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA.

Authors:  P Soussan; F Garreau; H Zylberberg; C Ferray; C Brechot; D Kremsdorf
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

4.  Hepatitis B virus DNA splicing in Lebanese blood donors and genotype A to E strains: implications for hepatitis B virus DNA quantification and infectivity.

Authors:  Mira El Chaar; Tamima El Jisr; Jean-Pierre Allain
Journal:  J Clin Microbiol       Date:  2012-07-11       Impact factor: 5.948

5.  Characterization and genetic analysis of alternatively spliced transcripts of hepatitis B virus in infected human liver tissues and transfected HepG2 cells.

Authors:  H L Wu; P J Chen; S J Tu; M H Lin; M Y Lai; D S Chen
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

6.  Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell.

Authors:  C T Bock; P Schranz; C H Schröder; H Zentgraf
Journal:  Virus Genes       Date:  1994-07       Impact factor: 2.332

7.  Detection of pre-C and core region mutants of hepatitis B virus in chronic hepatitis B virus carriers.

Authors:  T Wakita; S Kakumu; M Shibata; K Yoshioka; Y Ito; T Shinagawa; T Ishikawa; M Takayanagi; T Morishima
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

8.  Defective hepatitis B virus particles are generated by packaging and reverse transcription of spliced viral RNAs in vivo.

Authors:  S Terré; M A Petit; C Bréchot
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

9.  Characterization of the contribution of spliced RNAs of hepatitis B virus to DNA synthesis in transfected cultures of Huh7 and HepG2 cells.

Authors:  Teresa M Abraham; Eric B Lewellyn; Kathleen M Haines; Daniel D Loeb
Journal:  Virology       Date:  2008-07-26       Impact factor: 3.616

10.  Hepatitis B Spliced Protein (HBSP) Suppresses Fas-Mediated Hepatocyte Apoptosis via Activation of PI3K/Akt Signaling.

Authors:  Shu-Xiang Wu; Wan-Nan Chen; Zhen-Tang Jing; Wei Liu; Xin-Jian Lin; Xu Lin
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.